RxDoctor Payments Data

Tamara Vandyke, PA

Dermatology · Reno, NVNPI 1427053685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $646 and has fallen 55.5% since, to $288 in 2025. That places this record below the midpoint for dermatology clinicians in NV, where the typical reported total is $3,854.

$1,731in general payments, 2019–2025

Across 55 payments — averaging $31.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$374
  • AbbVie$249
  • Arcutis Biotherapeutics, Inc.$208
  • Johnson & Johnson$207
  • E.r. Squibb & Sons, L.L.C.$205
  • Sun Pharmaceutical Industries Inc.$112
  • plus $376 from 8 others

What the payments were for

  • Food & beverage$1,71699%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,731 in reported general payments places this provider in the 30th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$341,631
Medicare patients
1,395
Services billed
7,590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab12$83,421
Fluorouracil55$3,283
Clobetasol Propionate59$3,124
Ketoconazole103$2,095
Imiquimod49$1,570
Triamcinolone Acetonide149$1,314
Clindamycin Phosphate30$1,059
ValacyclovirValacyclovir Hcl27$931
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$600
Clotrimazole16$185
SsdSilver Sulfadiazine13$86
Mupirocin13$86

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →